Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
91,979,719
-
Share change
-
+6,135,462
-
Total reported value
-
$330,238,970
-
Put/Call ratio
-
149%
-
Price per share
-
$3.59
-
Number of holders
-
166
-
Value change
-
+$12,204,256
-
Number of buys
-
70
-
Number of sells
-
79
Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q1 2022
As of 31 Mar 2022,
INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by
166 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,979,719 shares.
The largest 10 holders included
STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, D. E. Shaw & Co., Inc., JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, Rafferty Asset Management, LLC, NORTHERN TRUST CORP, and MORGAN STANLEY.
This page lists
166
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.